#FDARecall
Explore tagged Tumblr posts
Text
FDA Issues Class I Tomato Recall Due to Salmonella Risk in 14 States
Many of you who are focused on spiritual growth also pay attention to your diets and eat lots of fresh fruits and vegetables. I think this recent news is important for my readers to know about. Please do your own research. In the past two days, the U.S. Food and Drug Administration (FDA) has escalated a tomato recall to a Class I level—the most serious category—due to potential Salmonella…
0 notes
Text
Tomato Recall Issued in 14 States Amid Salmonella Concerns
Source: economictimes.indiatimes.com
Tomato Recall Issued, The U.S. Food and Drug Administration (FDA) has announced a widespread recall of tomatoes distributed across 14 states due to concerns over potential salmonella contamination. The affected tomatoes come from two separate producers—Ray & Mascari Inc. and Williams Farms Repack LLC—and were distributed to various retail outlets and wholesalers between late April and early May.
Ray & Mascari Inc., based in Indiana, has recalled its four-count Vine Ripe tomatoes sold in plastic clamshell containers. These products, labeled “Packed by Ray & Mascari Inc..,” were sold at Gordon Food Service Stores in 11 states, including New York, Illinois, Michigan, and Pennsylvania. The recall stems from a notification by Hanshaw & Caping Farms of Immokalee, Florida, which had originally supplied the tomatoes and discovered a potential salmonella risk during routine facility checks.
Although no illnesses linked to the recalled products have been reported, the FDA advises consumers to either discard the tomatoes or return them if they remain unopened. Salmonella infections can lead to serious gastrointestinal symptoms and may pose a greater health risk to young children, the elderly, and individuals with compromised immune systems.
Second Supplier Expands Risk to Southern States
In a separate recall notice, Williams Farms Repack LLC announced it is pulling tomato products distributed to wholesalers in South Carolina, North Carolina, and Georgia. These tomatoes were shipped between April 23 and April 28, 2025. Though no retail-level recalls or consumer reports of illness have surfaced yet in connection to Williams Farms’ supply, the FDA’s precautionary alert was issued to prevent any potential health hazards.
Tomato Recall Issued, The recall does not specify the quantity of tomatoes affected, but both suppliers are cooperating with FDA guidelines and have initiated voluntary measures to remove the products from circulation. The agency emphasized that the recalls are a preventive step as investigations continue and further testing is conducted to determine the extent of the contamination.
Consumers who may have purchased tomatoes in affected states are urged to inspect labeling and packaging carefully. Any tomatoes marked with the Ray & Mascari Inc. label or purchased from wholesale markets in the Southern states during the specified dates should be treated as potentially hazardous.
Public Health Precautions and Industry Response
Salmonella is a common foodborne bacterium that can cause a range of symptoms, including fever, diarrhea, nausea, vomiting, and abdominal cramps. In rare but severe cases, it can lead to serious infections and complications, particularly in vulnerable populations.
Tomato Recall Issued, While no confirmed cases of illness have emerged in connection with the recalled tomatoes, public health officials are urging vigilance and swift disposal or return of the affected products. The FDA continues to monitor the situation and work with suppliers to ensure contaminated products are swiftly removed from store shelves and distribution channels.
This latest incident highlights the importance of rigorous safety protocols in food production and the need for transparency and rapid response in protecting public health. Both Ray & Mascari Inc. and Williams Farms Repack LLC have reiterated their commitment to food safety and are cooperating fully with the ongoing investigation.
Visit more of our news! Enterprise Wired
0 notes
Text
🚨 FDA Recalls Popular Skincare Products! Check Your Shelf NOW! 🚨
🚨 FDA Recalls Popular Skincare Products! Check Your Shelf NOW! 🚨
Hey, skincare lovers! 😱 Big news from the FDA – some popular acne treatments are being recalled due to the presence of benzene, a chemical that can cause cancer with long-term exposure. If you use La Roche-Posay, Proactiv, or Walgreens acne products, you NEED to check this out!
❌ Recalled Skincare Products:
🛑 La Roche-Posay Effaclar Duo Dual Action Acne Treatment (Lot: MYX46W, Exp: April 2025) 🛑 Walgreens Acne Control Cleanser (Lot: 23 09328, Exp: Sept 2025) 🛑 Proactiv Emergency Blemish Relief Cream (Lots: V3305A, V3304A, Exp: Oct 2025) 🛑 Proactiv Skin Smoothing Exfoliator (Lot: V4204A, Exp: July 2025) 🛑 SLMD Benzoyl Peroxide Acne Lotion (Lot: 2430600, Exp: March 2025) 🛑 Walgreens Tinted Acne Treatment Cream (Lot: 49707430, Exp: March 2026)
❓ What is Benzene & Why is This a Big Deal?
Benzene is a harmful chemical linked to leukemia and other blood cancers. The FDA found unsafe levels in these products, and while they say the risk is low, it’s best to be cautious!
🏪 What Should You Do?
✔️ Check your acne products for these names and lot numbers. ✔️ Stop using them if you’re worried! ✔️ Talk to your doctor if you have concerns.
The recall is retail-level, meaning stores are pulling these products off shelves. If you still have one, don’t panic! The FDA says the cancer risk is low, even with regular use.
📢 Stay Updated & Protect Your Skin!
For more details, visit the official FDA recall page: 🔗 FDA Recall Info
✨ Want more skincare updates? Click here: 🔗 More Info
👉 Share this post to spread awareness! Stay safe, and always check your products! 💙💄💫
1 note
·
View note
Text
Urgent Recall Notice: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies
Recall Notice: Recently, the FDA issued an urgent recall notice for Diamond Shruumz-Brand Chocolate Bars, Cones, and Gummies due to reports of severe illnesses associated with consuming these products. This blog post aims to provide you with essential information about the ongoing investigation and steps you can take to protect yourself and your loved ones. Recall Details:The FDA advises…
0 notes
Text
It Wasn’t Really Decaf: FDA Recalls 692 Coffee Cases Over Labeling Mix-Up
Okay, coffee fam, brace yourselves—this is wild! The FDA just announced a recall of 692 cases of so-called “decaf” coffee that’s actually packing a caffeine punch. Turns out, some mislabeled bags slipped through, and they could be a real problem for anyone sensitive to caffeine (or just trying to cut back, let’s be real).
If you’ve got some decaf stashed in your pantry, now’s the time to double-check those labels. Stay safe out there, sippers! Full details here: https://urlhub.pro/89b5d0
#FDARecall #CoffeeMixUp #DecafFail #HealthAlert #USANews #CoffeeLoversUnite
1 note
·
View note
Text
Health News
Savage Pet, based in El Cajon, California, has announced a recall of its Savage Cat Food Chicken, sold in both large 84 oz. and small 21 oz. boxes, due to a possible bird flu contamination risk #healthnews #AnimalNews #FoodRecall #FDA #FDARecall
0 notes
Text
Urgent Recall: FDA Issues Public Health Alert for Recalled Everest and Maggi Spices Over Salmonella Risk
Urgent Recall: FDA Issues Public Health Alert for Recalled Everest and Maggi Spices Over Salmonella Risk. #FDARecall #Maggi #Everest #Spices
The U.S. Food and Drug Administration (FDA) has issued a public health alert concerning the recall of certain Everest and Maggi spices because of a potential Salmonella risk. The products under the spotlight include Everest Garam Masala, Everest Sambhar Masala, and Maggi Masala ae Magic, all of which were not labeled for distribution in the United States. Amin Trading Agency LLC, based in…
View On WordPress
0 notes
Photo

FDA Issues Warning About Illnesses, Deaths Linked to Midwestern Pet Foods The FDA issued a public warning on Tue... Read the rest on our site with the url below https://worldwidetweets.com/fda-issues-warning-about-illnesses-deaths-linked-to-midwestern-pet-foods/?feed_id=73211&_unique_id=611fad8d270bc #catfoodrecall #dogillnesspetfood #dogsdiefromdogfood #dogsdiepetfood #fdapetfood #fdarecall #fdarecallpetfood #MidwesternPetFoods #petfoodrecall
#catfoodrecall#dogillnesspetfood#dogsdiefromdogfood#dogsdiepetfood#fdapetfood#fdarecall#fdarecallpetfood#MidwesternPetFoods#petfoodrecall
0 notes
Photo

FDA Issues Warning About Illnesses, Deaths Linked to Midwestern Pet Foods The FDA issued a public warning on Tue... Read the rest on our site with the url below https://worldwidetweets.com/fda-issues-warning-about-illnesses-deaths-linked-to-midwestern-pet-foods/?feed_id=73210&_unique_id=611fad8bd8ec8 #catfoodrecall #dogillnesspetfood #dogsdiefromdogfood #dogsdiepetfood #fdapetfood #fdarecall #fdarecallpetfood #MidwesternPetFoods #petfoodrecall
#catfoodrecall#dogillnesspetfood#dogsdiefromdogfood#dogsdiepetfood#fdapetfood#fdarecall#fdarecallpetfood#MidwesternPetFoods#petfoodrecall
0 notes
Photo

The FDA is doing a recall on these products as they contain traces of Asbestos #FDARecall #Asbestos https://www.instagram.com/p/Bu0LV_iHFxS/?utm_source=ig_tumblr_share&igshid=1c2clkcgtj40l
0 notes
Link
0 notes
Text
#GodMorningSunday
Positive change is possible only with Satsang of Saint Rampal ji Maharaj Ji
To Know More Visit Satlok Ashram Youtube Channel ..
@SaintRampalJiM #SundayMotivation
@KShriniwasRao @FDArecalls @aajtak @aplusapp @kdbowe #SundayMorning #SundayThoughts

0 notes
Text
Company Recalls Injectable CBD Products Following FDA Warning Letter
A Food and Drug Administration (FDA) letter warning a company about its marketing of injectable CBD products has led to a voluntary recall that the federal agency announced on Wednesday.
Biota Biosciences received the letter last month, with FDA directing the firm to cease sales of its line of CBD vials, which it markets as a pain reliever that serves as an alternative to opioids and can help with detoxification.
The agency said the company was violating federal statutes both by engaging in interstate commerce of an unapproved new drug and failing to properly label the products by neglecting to include directions for use.
“Injectable drug products can pose a serious risk of harm to users because they are delivered directly into the bloodstream and bypass many of the body’s natural defenses against toxic ingredients, toxins, or dangerous organisms that can lead to serious and life-threatening conditions such as septicemia or sepsis,” FDA wrote.
Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval https://t.co/hAYSW5IxDX pic.twitter.com/QxxoD8pCNI
— U.S. FDA Recalls (@FDArecalls) May 21, 2020
In a public response published on Friday, the company told consumers that “we would like to convey that the executive and management team at Biota Biosciences take full responsibility for these observations and understand the gravity of the risk to consumers by posting these unapproved claims and intended use on our website.”
Products subject to the recall include formulations of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin. “All customers who received this product will have the choice to keep any remaining product or receive a full refund for returning unused products,” the firm said.
Since receiving FDA’s warning letter, the company says has pulled all the products, provided the agency with a “root cause and corrective action plan” and launched a voluntary recall of the vials.
According to the original warning letter, the CBD products meet the definition of a drug subject to FDA regulation because “they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body,” the letter continues.
FDA identified several examples of medical claims Biota Biosciences made about their CBD vials in advertising:
“Fighting the opioid epidemic… BIOTA Biosciences produces and distributes effective all-natural alternatives with no side-effects. Join the growing ranks of pain, oncology, psychiatry, naturopathy healthcare professionals utilizing BIOTA Sterile CBD Vials.”
“VISION: OPIOID-FREE FUTURE… Our goal is to supply the world with pharmaceutical grade, all natural products containing cannabidiol and other natural compounds. We believe strongly that pharmaceutical grade hemp oil will drastically reduce the need for opioid-based pain relief and eliminate the global opioid epidemic by providing a safe and natural alternative.”
“Instant relief for patients that are symptomatic of inflammatory auto-immune diseases”
While the products lack directions for use, the company has claimed that they bypass liver absorption and deliver CBD “directly into your bloodstream.”
Further, FDA stressed that even if the labels did contain usage information, they would still be in violation.
“New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA,” the letter states. “FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective.”
The injectable CBD vials “are offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners; therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes.”
“The violations cited in this letter are not intended to be an all-inclusive statement of violations that exist in connection with your marketed products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. According to your website, you manufacture many other types of CBD containing products. It is your responsibility to ensure that your firm complies with all requirements of federal law, including FDA regulations.”
FDA gave Biota Biosciences 15 days within the receipt of the letter to notify them about corrective steps they’ve taken. Failure to resolve the issues could have resulted in “legal action without further notice, including, without limitation, seizure and injunction.”
In its public statement, Biota Biosciences said that so far “no adverse or serious adverse events have been reported in relation to these products.” FDA is urging consumers may have such experiences to report them to its MedWatch Adverse Event Reporting program.
This is one of the latest statements FDA has made about CBD companies that are not meeting its standards.
Earlier this week, the agency publicized a voluntary recall of another CBD product from a different company, notifying consumers about potentially high levels of lead in a batch of tinctures.
FDA has said that it is currently targeting companies that make especially outlandish and unsanctioned claims about the therapeutic potential of their cannabis products.
For example, it sent a warning letter to a CBD company owned by a former NFL player after advertisements it displayed suggested its products could treat and prevent a coronavirus infection.
FDA has previously issued warnings to other CBD companies that have made unsubstantiated claims about the therapeutic potential of their products.
Although the agency does not currently approve of CBD as a food item or dietary supplement, it is in the process of developing regulations that may allow for such marketing.
FDA Notifies Public About Recall Of CBD Product That Tested High For Lead
Photo courtesy of Flickr/Marco Verch.
The post Company Recalls Injectable CBD Products Following FDA Warning Letter appeared first on Marijuana Moment.
from Updates By Jane https://www.marijuanamoment.net/company-recalls-injectable-cbd-products-following-fda-warning-letter/
0 notes
Photo
Election Year Have you considered THE CORRUPTION IN Chicago politics & Chicago Police @thehill @gov @OIGatHHS @StateOIG @TheSSAOIG @OIGUSPS @VetAffairsOIG @EducationOIG @DOTInspectorGen @oig @US_FDA @FDArecalls @USDAFoodSafety @USDA @fedgrants_gov @HUDOIG @USPISpressroom @customs
0 notes
Text
FDA Expands Cinnamon Applesauce Recall: Lead Contamination Concerns
FDA expands recall of cinnamon applesauce pouches due to lead contamination. Illnesses potentially linked to recalled product reported. Investigation is ongoing. #FDARecall #LeadContamination #FoodSafety
FDA Advises Parents and Caregivers Not to Buy or Feed WanaBana Apple Cinnamon Fruit Puree Pouches to Toddlers and Young Children Because of Elevated Lead Levels In a recent development, the Food and Drug Administration (FDA) has issued an updated advisory regarding the investigation of elevated lead levels in cinnamon applesauce pouches. This update includes an expanded recall from WanaBana LLC,…
View On WordPress
0 notes
Photo
Election Year Have you considered THE CORRUPTION IN Chicago politics & Chicago Police @thehill @gov @OIGatHHS @StateOIG @TheSSAOIG @OIGUSPS @VetAffairsOIG @EducationOIG @DOTInspectorGen @oig @US_FDA @FDArecalls @USDAFoodSafety @USDA @fedgrants_gov @HUDOIG @USPISpressroom @customs
0 notes